You are here

Regeneron

Bayer, Regeneron's eye drug shown to work at higher dose, longer intervals

Yahoo/Reuters

Thu, 09/8/22 - 04:33 pm

diabetic macular edema

wet age-related macular degeneration

Alnylam clears phase 2 test for Regeneron-partnered nephropathy med, as it looks to play catch-up against Calliditas

Fierce Biotech

Tue, 08/30/22 - 11:48 am

immunoglobin A nephropathy

clinical trials

Alnylam Reports Positive Results from Phase 2 Study of Investigational Cemdisiran for the Treatment of IgA Nephropathy

Businesswire

Mon, 08/29/22 - 10:26 am

Alnylam Pharmaceuticals

clinical trials

immunoglobultin A nephropathy

Drug makers leave the pain behind

EP Vantage

Fri, 08/26/22 - 10:26 am

Ampio Pharmaceuticals

Eliem Therapeutics

Teva Pharamceutical

Vertex Pharmaceuticals

Kodiak matches Regeneron’s Eylea in macular edema phase 3, lighting Beacon of hope after flop

Fierce Biotech

Tue, 08/9/22 - 06:34 am

Kodiak Sciences

clinical trials

Regeneron's Dupixent and Eylea Offset Drop in COVID-19 Antibody Sales

BioSpace

Wed, 08/3/22 - 09:19 pm

Look out, Regeneron. As the threat from Roche's Vabysmo grows, one team of analysts slashes its Eylea sales estimate

Fierce Pharma

Mon, 07/25/22 - 10:00 pm

Regeneron, Sanofi Look to Extend Dupixent into Young Kids with Eosinophilic Esophagitis

BioSpace

Thu, 07/14/22 - 11:49 am

eosinophilic esophagitis

Regeneron completes acquisition of Sanofi’s stake in Libtayo

Pharmaceutical Business Review

Mon, 07/4/22 - 11:58 pm

Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA

Motley Fool

Mon, 06/27/22 - 10:12 am

eosinophilic esophagitis

Regeneron Breaks Ground on $1.8B NY Expansion Project

BioSpace

Thu, 06/23/22 - 10:41 am

Regeneron's Eylea could lose 30% of its patients to Roche's Vabysmo over the next year: analyst survey

Fierce Pharma

Mon, 06/13/22 - 09:46 pm

FDA approves Sanofi and Regeneron’s Dupixent for atopic dermatitis in young children

Pharmaceutical Business Review

Wed, 06/8/22 - 10:44 am

atopic dermatitis

Regeneron purchases Sanofi’s stake in Libtayo collaboration

Biopharma Reporter

Thu, 06/2/22 - 10:27 am

Regeneron's cholesterol drug war heats up with lawsuit over Amgen's 'illegal' bundling scheme

Fierce Pharma

Wed, 06/1/22 - 07:36 pm

FDA grants speedy review to Dupixent rare skin disease

Pharmaforum

Tue, 05/31/22 - 10:43 am

prurigo nodularis

Why Regeneron Investors Shouldn't Fear Its Patent Cliff

Motley Fool

Thu, 05/26/22 - 10:08 am

Sanofi's Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis

Fierce Pharma

Sun, 05/22/22 - 09:15 pm

eosinophilic esophagitis

Is Regeneron In Trouble After Sales Declined 40% In a Single Quarter?

Motley Fool

Thu, 05/12/22 - 10:15 am

The 12 Top Biotech Companies Hiring Now

BioSpace

Tue, 05/10/22 - 10:26 pm

Moderna Therapeutics

Waters Corporation

Gilead Sciences

Emergent BioSolutions

Pages